213 related articles for article (PubMed ID: 28416738)
1. Differential expression of folate receptor 1 in medulloblastoma and the correlation with clinicopathological characters and target therapeutic potential.
Liu H; Sun Q; Zhang M; Zhang Z; Fan X; Yuan H; Li C; Guo Y; Ning W; Sun Y; Song Y; Yu C
Oncotarget; 2017 Apr; 8(14):23048-23060. PubMed ID: 28416738
[TBL] [Abstract][Full Text] [Related]
2. High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells.
da Silva PBG; Teixeira Dos Santos MC; Rodini CO; Kaid C; Pereira MCL; Furukawa G; da Cruz DSG; Goldfeder MB; Rocha CRR; Rosenberg C; Okamoto OK
Oncotarget; 2017 Mar; 8(12):19192-19204. PubMed ID: 28186969
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA CCAT1 promotes cell proliferation and metastasis in human medulloblastoma via MAPK pathway.
Gao R; Zhang R; Zhang C; Zhao L; Zhang Y
Tumori; 2018; 104(1):43-50. PubMed ID: 28777430
[TBL] [Abstract][Full Text] [Related]
4. MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma.
Wang C; Yun Z; Zhao T; Liu X; Ma X
Cell Physiol Biochem; 2015; 36(4):1430-9. PubMed ID: 26160036
[TBL] [Abstract][Full Text] [Related]
5. Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
Sandén E; Dyberg C; Krona C; Visse E; Carén H; Northcott PA; Kool M; Ståhl N; Persson A; Englund E; Johnsen JI; Siesjö P; Darabi A
J Neurooncol; 2015 May; 123(1):1-13. PubMed ID: 25820321
[TBL] [Abstract][Full Text] [Related]
6. SnapShot: Medulloblastoma.
Rusert JM; Wu X; Eberhart CG; Taylor MD; Wechsler-Reya RJ
Cancer Cell; 2014 Dec; 26(6):940-940.e1. PubMed ID: 25490452
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
[TBL] [Abstract][Full Text] [Related]
8. Folate receptor-α (FOLR1) expression and function in triple negative tumors.
Necela BM; Crozier JA; Andorfer CA; Lewis-Tuffin L; Kachergus JM; Geiger XJ; Kalari KR; Serie DJ; Sun Z; Moreno-Aspitia A; O'Shannessy DJ; Maltzman JD; McCullough AE; Pockaj BA; Cunliffe HE; Ballman KV; Thompson EA; Perez EA
PLoS One; 2015; 10(3):e0122209. PubMed ID: 25816016
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and meta-analysis of higher expression of folate receptor alpha (FOLR1) predicts poor cancer prognosis.
Liu Y; Lian T; Yao Y
Biomarkers; 2020 Jul; 25(5):367-374. PubMed ID: 32421366
[TBL] [Abstract][Full Text] [Related]
10. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle targeted folate receptor 1-enhanced photodynamic therapy for lung cancer.
Kato T; Jin CS; Ujiie H; Lee D; Fujino K; Wada H; Hu HP; Weersink RA; Chen J; Kaji M; Kaga K; Matsui Y; Wilson BC; Zheng G; Yasufuku K
Lung Cancer; 2017 Nov; 113():59-68. PubMed ID: 29110850
[TBL] [Abstract][Full Text] [Related]
13. EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.
Smits M; van Rijn S; Hulleman E; Biesmans D; van Vuurden DG; Kool M; Haberler C; Aronica E; Vandertop WP; Noske DP; Würdinger T
Clin Cancer Res; 2012 Aug; 18(15):4048-58. PubMed ID: 22696229
[TBL] [Abstract][Full Text] [Related]
14. miR miR on the wall, who's the most malignant medulloblastoma miR of them all?
Wang X; Holgado BL; Ramaswamy V; Mack S; Zayne K; Remke M; Wu X; Garzia L; Daniels C; Kenney AM; Taylor MD
Neuro Oncol; 2018 Feb; 20(3):313-323. PubMed ID: 28575493
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
[TBL] [Abstract][Full Text] [Related]
16. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.
Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P
J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.
de Haas TG; Kool M
Clin Neuropathol; 2007; 26(3):93-110. PubMed ID: 19157001
[TBL] [Abstract][Full Text] [Related]
18. Redefining the molecular substructure of medulloblastoma.
Benmaamar R
Lancet Oncol; 2017 Sep; 18(9):e514. PubMed ID: 28757377
[No Abstract] [Full Text] [Related]
19. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesterase.
Lim SH; Choi SA; Lee JY; Wang KC; Phi JH; Lee DH; Song SH; Song JH; Jin X; Kim H; Lee HJ; Lim I; Kim SU; Kim SK
Cancer Gene Ther; 2011 Nov; 18(11):817-24. PubMed ID: 21869821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]